Persson Magnus is a director of Avalo Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Avalo Therapeutics, Inc.
21 Dec 23
4
Avalo Therapeutics, Inc.
5 Jul 23
4
Avalo Therapeutics, Inc.
4 Apr 23
4
Avalo Therapeutics, Inc.
3 Jan 23
4
Avalo Therapeutics, Inc.
3 Oct 22
4
Avalo Therapeutics, Inc.
5 Jul 22
4
Avalo Therapeutics, Inc.
16 Jun 22
4
Avalo Therapeutics, Inc.
4 Apr 22
4
Avalo Therapeutics, Inc.
4 Jan 22
4
Avalo Therapeutics, Inc.
4 Oct 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
20 Dec 23 | AVTX Avalo Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 0.043 | 3,334 | 143.36 | 3,334 |
31 Mar 23 | AVTX Avalo Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 1.75 | 7,222 | 12.64 k | 7,222 |
30 Dec 22 | AVTX Avalo Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 5.0401 | 2,536 | 12.78 k | 2,536 |